Sengenics is a company that develops and provides immunoproteomics technologies and services for biomarker discovery. The company markets two products, i-Ome Cancer and i-Ome Discovery, which are protein microarrays that allow customers to profile autoantibodies against a large number of protein antigens. Sengenics' technology is based on a patented KREX® protein folding technology that ensures that the proteins on the microarrays are correctly folded, increasing the accuracy and reproducibility of the results. Sengenics is also a certified Service Provider for Asia through their partnership with SML Meditree.

COM:SENGENICS

Sengenics